PTCE domain - 18.75% of the exam

Federal Requirements

Federal Requirements is 18.75% of the PTCE exam. These are the objectives it covers, each with practice questions, with every answer explained.

The domain in numbers

60
Practice questions
6
Objectives
29
Medium
31
Hard

Where people go wrong

  • Attaching a DEA form to the wrong event

    The wrong answers pair a DEA form with an event it does not serve: Form 41 for a theft, Form 222 for a loss report or a registration certificate, Form 106 or Form 41 for ordering stock, and Form 224 for a theft report. Each form has one job. DEA Form 222, or its electronic CSOS equivalent, orders Schedule I and II substances. DEA Form 106 reports a significant loss or theft. DEA Form 41 records destruction of controlled substances. Form 224 is the registration application.

    See it in a sample question
  • Carrying a refill rule across to the wrong schedule

    The wrong answers move a refill rule to a drug class it does not govern. The 5-refill allowance of Schedule III to V is applied to Schedule II, which permits no refills at all, and the 12-month window of non-controlled legend drugs is applied to controlled refills. Schedule III to V refills expire 6 months after the written date. The Schedule II bar on refills is also misused in reverse, to refuse a Schedule III to V transfer that federal law allows one time between pharmacies without a shared real-time database.

    See it in a sample question
  • Picking the wrong FDA recall class

    The wrong answers choose a class above or below the one the hazard sets, or name a market withdrawal. Class I covers a reasonable probability of serious adverse health consequences or death. Class II covers temporary or medically reversible harm with a remote probability of serious consequences. Class III covers a violation unlikely to cause any adverse health consequence. A market withdrawal is a minor issue not subject to FDA legal action, so it is not one of the three recall classes.

    See it in a sample question
  • Resolving suspect product without quarantine

    When a product looks illegitimate, the wrong answers settle it quickly: dispensing it, returning it to the wholesaler, editing the record to remove a mismatch, or destroying it quietly. Each skips the investigation. Under DSCSA, product with a reason to believe it is counterfeit, diverted or otherwise illegitimate, such as a serial number or lot number that does not match the transaction information, is suspect product. It is quarantined and investigated before any decision to clear or dispose of it.

    See it in a sample question
  • Sending P-listed waste down an ordinary route

    The wrong answers route discarded P-listed product through an ordinary channel: down the drain, into general trash, in with non-hazardous waste, or into recycling. A discarded commercial chemical product that is acutely hazardous, such as nicotine or warfarin, belongs on the P-list and goes into the hazardous waste stream. Residues stay regulated, so even a vial that looks empty receives the stricter container handling.

    See it in a sample question

Objectives in this domain

What to study

The official documents this domain's practice questions cite most.

Sample questions from this domain

Free sampleFederal Requirementshard

A community pharmacy needs to order a supply of hydromorphone, a Schedule II medicine, from its wholesaler. The pharmacy is not registered for the electronic ordering system and intends to use a paper order. Which document must the pharmacy use to lawfully order this Schedule II product?

  • AA signed purchase order on pharmacy letterhead listing the product and quantity
  • BDEA Form 41, recording the controlled substances being transferred
  • CDEA Form 222, the official order form for Schedule II controlled substances Correct
  • DDEA Form 106, submitted to authorise the wholesale purchase
Recognise that paper ordering of Schedule II controlled substances requires DEA Form 222 or the electronic ordering equivalent. Schedule II substances carry the strictest distribution controls, so federal law mandates an official order form, DEA Form 222, to create an auditable record of every transfer between registrants rather than an ordinary purchase order.

Why A is wrong: Letterhead purchase orders are used for routine non-controlled stock, but federal law requires a specific official order form for paper ordering of Schedule II products, so this is insufficient.

Why B is wrong: Form 41 is the record used to document destruction of controlled substances, not to order stock, so candidates who confuse the form numbers will pick this wrongly.

Why C is correct: Federal law requires Schedule II substances ordered on paper to be requested using DEA Form 222 (or its electronic equivalent through the controlled ordering system), making this the correct document.

Why D is wrong: Form 106 reports significant loss or theft of controlled substances and has no role in ordering, so it is a tempting but incorrect form-number swap.

Free sampleFederal Requirementshard

A patient, Priya Nandakumar, asks her current pharmacy to transfer the remaining refills of her phenobarbital prescription, a Schedule IV medicine, to a second pharmacy that is not electronically linked by a shared real-time database. The original prescription had three refills authorised, none yet used. How many refills may lawfully be transferred?

  • AOnly one refill may be transferred, with the remaining two staying at the original pharmacy.
  • BNo refills may be transferred, because Schedule IV prescriptions cannot move between pharmacies.
  • CAll three remaining refills may be transferred on a one-time basis to the receiving pharmacy. Correct
  • DAll three refills may be transferred and the receiving pharmacy may then transfer them onward again.
Schedule III to V refills may be transferred between non-linked pharmacies one time only, carrying all remaining authorised refills in that single transfer. Federal regulation allows a one-time transfer of remaining Schedule III to V refills between pharmacies that do not share a real-time database; the whole balance of refills moves in that transaction and cannot be repeatedly relayed.

Why A is wrong: Tempting because the transfer itself is a one-time event, but the one-time limit applies to the act of transferring, not the number of refills moved, so all remaining refills go together.

Why B is wrong: Tempting because Schedule II prescriptions cannot have refills transferred, but Schedule III to V refills are transferable, so a blanket refusal misapplies the Schedule II rule.

Why C is correct: Correct: between pharmacies that do not share a real-time online database, the transfer of Schedule III to V refill information is permitted one time only, and all remaining authorised refills transfer in that single transaction.

Why D is wrong: Tempting because the refills do transfer, but for non-linked pharmacies the transfer is allowed only once, so onward re-transfer of the same refills is not permitted.

Free sampleFederal Requirementsmedium

A wholesaler notifies a pharmacy that a batch of an injectable potassium chloride concentrate has been recalled because a labelling error could lead to a dose that causes death or serious irreversible harm. Under the FDA classification scheme, how should this recall be categorised?

  • AClass II, because a labelling error involves the product container rather than the drug substance itself.
  • BClass III, because the violation is a documentation problem unlikely to harm patients.
  • CMarket withdrawal, because the firm is removing the product for a minor issue at its own discretion.
  • DClass I, because there is a reasonable probability that use of the product will cause serious adverse health consequences or death. Correct
Recognise that a defect with a reasonable probability of death or serious irreversible harm defines a Class I recall. FDA assigns recall classes by the health hazard the violative product poses; Class I is triggered when there is a reasonable probability that use will cause serious adverse health consequences or death, which a potentially lethal dosing or labelling error meets.

Why A is wrong: A Class II recall covers products that may cause temporary or medically reversible harm, with a remote probability of serious consequences; a labelling defect that can deliver a lethal dose exceeds that threshold, so this is too low a class.

Why B is wrong: Class III is reserved for violations not likely to cause adverse health consequences, such as minor cosmetic or container defects; a dosing error capable of killing a patient plainly does not fit.

Why C is wrong: A market withdrawal addresses a minor issue not subject to FDA legal action, which is tempting given that firms initiate it voluntarily, but a defect posing a real risk of death is a reportable recall, not a withdrawal.

Why D is correct: Class I is the most serious category and applies precisely when use of or exposure to a violative product carries a reasonable probability of serious adverse health consequences or death, which a potentially lethal dosing error satisfies.

Free sampleFederal Requirementsmedium

While shelving an order, a technician notices that a bottle of levothyroxine, lot LVX-3320, has a product identifier on the carton whose serial number does not match the number recorded in the transaction information received with the shipment. The technician suspects the product may be illegitimate. What is the most appropriate immediate action under DSCSA?

  • ADispense the remaining bottles quickly to reduce on-hand exposure before the supplier is contacted.
  • BCorrect the serial number in the pharmacy record to match the carton and continue stocking the bottle.
  • CQuarantine the product physically or electronically so it is separated from sellable stock while an investigation is conducted. Correct
  • DReturn the bottle to the supplier on the next routine pickup without recording a suspect determination.
A product with a discrepancy suggesting it may be illegitimate must be quarantined and investigated under DSCSA suspect-product rules. When a product identifier or other indicator suggests a drug may be counterfeit, diverted, or otherwise suspect, DSCSA requires the dispenser to quarantine it and investigate before it can be returned to sellable stock or dispensed.

Why A is wrong: This is tempting as a way to clear inventory, but dispensing suspect product to patients is exactly what DSCSA quarantine provisions are designed to prevent.

Why B is wrong: Editing the record to remove the mismatch hides the discrepancy that triggers a suspect determination, defeating the verification that DSCSA requires.

Why C is correct: DSCSA directs that a product identified as suspect be quarantined and investigated so it cannot be dispensed while its legitimacy is being determined.

Why D is wrong: Returning product feels like resolving the problem, but it skips the quarantine and investigation steps DSCSA mandates and loses the documentation trail.

Free sampleFederal Requirementsmedium

During a stock check, a technician finds an unopened bottle of nicotine polacrilex bulk powder, lot NC-2208, that the pharmacy no longer uses. The pharmacist notes that commercial chemical products containing nicotine are listed on the EPA P-list when discarded. What is the technician's correct first step in handling this discarded product?

  • AReturn it to the wholesaler for credit because an unopened bottle is still saleable inventory.
  • BEmpty the powder into the sanitary sewer and recycle the empty bottle.
  • CPlace it in the blue recycling stream because nicotine is a naturally derived plant compound.
  • DManage it as P-listed acutely hazardous waste, placing it in the designated hazardous waste container and recording it for the hazardous waste manifest. Correct
Treat discarded commercial nicotine products as P-listed acutely hazardous waste requiring segregation and manifested disposal. Nicotine and certain salts appear on the EPA P-list, meaning a discarded commercial chemical product containing nicotine is acutely hazardous waste; it must be segregated into the hazardous waste container and tracked rather than sold, sewered, or recycled.

Why A is wrong: It is tempting since the bottle is unopened, but the pharmacy has designated it as discarded, and a P-listed product slated for disposal must be managed as hazardous waste rather than treated as returnable stock.

Why B is wrong: Sewering may seem like a quick fix, but disposing of a P-listed acutely hazardous waste down the drain violates federal hazardous waste handling requirements.

Why C is wrong: The plant origin is a distractor; once discarded, the commercial nicotine product is a regulated P-listed hazardous waste and cannot be routed through ordinary recycling.

Why D is correct: Discarded commercial chemical products containing nicotine fall under the EPA P-list, so the bottle must enter the acutely hazardous waste stream and be tracked for proper manifested disposal.

Other domains in this exam

See also the PTCE cert hub, the study guide, and the cheat sheet.

Examworthy is not affiliated with or endorsed by PTCB. Original, blueprint-aligned practice material only.